STOCK TITAN
  1. Home
  2. Sec-filings
  3. MRMD
  4. [Form 4] MARIMED INC. Insider Trading Activity

MariMed (MRMD) CEO Jon Levine exercises RSUs and has shares withheld for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MARIMED INC. President and CEO Jon R. Levine reported equity compensation activity involving company common stock and restricted stock units. He exercised 46,875 RSUs into an equal number of common shares, and 16,243 shares were withheld by the company to cover tax obligations related to this vesting.

Following these transactions, Levine directly held 21,354,861 shares of common stock. An additional 6,684,640 shares are held by the Jon Levine Family Trust for the benefit of his spouse and children, for which he disclaims beneficial ownership. After this vesting, 140,625 RSUs from the November 29, 2024 grant remain outstanding, scheduled to vest in three equal installments on November 29, 2026, May 29, 2027 and November 29, 2027.

Positive

  • None.

Negative

  • None.
Insider Levine Jon R
Role President and CEO
Type Security Shares Price Value
Exercise Restricted Stock Units (RSU) 46,875 $0.00 --
Exercise Common stock 46,875 $0.00 --
Tax Withholding Common stock 16,243 $0.0805 $1K
holding Common stock -- -- --
Holdings After Transaction: Restricted Stock Units (RSU) — 140,625 shares (Direct, null); Common stock — 21,354,861 shares (Direct, null); Common stock — 6,684,640 shares (Indirect, By the Jon Levine Family Trust)
Footnotes (1)
  1. RSUs convert to shares of common stock on a one-for-one basis. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs. These shares are held in trust for the benefit of the Reporting Person's spouse and children. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The RSUs were granted on November 29, 2024; the remaining RSUs under this grant will vest in three equal installments on each of November 29, 2026, May 29, 2027 and November 29, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
RSUs exercised 46,875 shares Restricted Stock Units converted to common stock on May 29, 2026
Shares withheld for taxes 16,243 shares at $0.0805 Withheld to satisfy tax obligations on RSU vesting
Direct common shares after transaction 21,354,861 shares Direct ownership following May 29, 2026 transactions
Indirect trust holdings 6,684,640 shares Held by Jon Levine Family Trust; beneficial ownership disclaimed
Remaining RSUs 140,625 RSUs Outstanding from November 29, 2024 grant after current vesting
Future vesting dates Nov 29 2026, May 29 2027, Nov 29 2027 Three equal installments for remaining RSUs
RSU conversion ratio 1 RSU : 1 share RSUs convert to common stock on a one-for-one basis
Restricted Stock Units (RSU) financial
"security_title: "Restricted Stock Units (RSU)""
tax withholding obligations financial
"withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting"
Section 16 regulatory
"beneficial owner of these securities for purposes of Section 16 or for any other purpose"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
vesting financial
"in connection with the vesting of RSUs"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Levine Jon R
(Last)(First)(Middle)
C/O MARIMED INC.
10 OCEANA WAY
(Street)
NORWOOD, MASSACHUSETTS 02062
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock05/29/2026M46,875A$0(1)21,354,861D
Common stock05/29/2026F16,243(2)D$0.080521,338,618D
Common stock6,684,640IBy the Jon Levine Family Trust(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units (RSU)(1)05/29/2026M46,875 (4) (4)Common Stock, par value $.001 per share46,875$0140,625D
Explanation of Responses:
1. RSUs convert to shares of common stock on a one-for-one basis.
2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
3. These shares are held in trust for the benefit of the Reporting Person's spouse and children. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
4. The RSUs were granted on November 29, 2024; the remaining RSUs under this grant will vest in three equal installments on each of November 29, 2026, May 29, 2027 and November 29, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
Remarks:
/s/ Jon R. Levine06/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did MariMed (MRMD) CEO Jon Levine report in this Form 4?

Jon Levine reported routine equity compensation activity, exercising 46,875 restricted stock units into common shares. The company withheld 16,243 shares for taxes, updating his direct and indirect holdings and the remaining RSU balance under a prior grant.

How many MariMed (MRMD) shares does Jon Levine hold after these transactions?

After these transactions, Jon Levine directly holds 21,354,861 MariMed common shares. A further 6,684,640 shares are held by the Jon Levine Family Trust for his spouse and children, for which he disclaims beneficial ownership under Section 16 rules.

Why were 16,243 MariMed (MRMD) shares disposed of in this filing?

The 16,243 shares were withheld by MariMed to satisfy tax withholding obligations tied to RSU vesting, coded as a tax-withholding disposition. This is not an open-market sale but a standard mechanism to cover related tax liabilities on vested stock awards.

What RSU grant details are disclosed for MariMed (MRMD) CEO Jon Levine?

The RSUs were granted on November 29, 2024 and convert to common stock one-for-one. After the reported vesting, 140,625 RSUs remain, vesting in three equal installments on November 29, 2026, May 29, 2027 and November 29, 2027.

How many restricted stock units did Jon Levine convert into MariMed (MRMD) shares?

Jon Levine exercised 46,875 restricted stock units, converting them into 46,875 MariMed common shares at a conversion price of $0.0000 per share. This reflects previously granted equity compensation now settled in common stock.

What is the nature of Jon Levine’s indirect MariMed (MRMD) share ownership?

Levine’s indirect holding of 6,684,640 shares is through the Jon Levine Family Trust, benefiting his spouse and children. He expressly disclaims beneficial ownership of these securities, and the disclosure clarifies this for Section 16 reporting purposes.